<Record>
<Term>Photosensitizing Agents</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Dermatologic Agents</ParentTerm>
<ParentTerm>Radiation-Sensitizing Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Dermatologic Agents/Photosensitizing Agents</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Physiological Effects of Drugs/Radiation-Sensitizing Agents/Photosensitizing Agents</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Photosensitizing Agents</BroaderTerm>
<BroaderTerm>Dermatologic Agents</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Radiation-Sensitizing Agents</BroaderTerm>
<BroaderTerm>Physiological Effects of Drugs</BroaderTerm>
<Synonym>Photosensitizers</Synonym>
<Synonym>Photosensitizing Agents</Synonym>
<Description>Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.</Description>
<Source>MeSH</Source>
</Record>
